Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM shared a post on LinkedIn:
“It was an honor to represent the TRANSLATE-IT CRCM Department of CRCM – Marseille Cancer Research Center, where I co-chair alongside Joseph Ciccolini, at the 11th Course French-speaking Digestive Cancerology Days (ABCD), held as part of the Francophone Digestive Cancer Days (Journées Francophones de Cancérologie Digestive, JFCD) 2025 in Paris.
During this esteemed educational and scientific event, I presented on predictive signatures for pancreatic cancer therapy, emphasizing their potential to refine treatment strategies and improve outcomes. Joseph contributed to the session on new therapeutic approaches, offering a compelling analysis of antibody-drug conjugates (ADCs) and bispecific antibodies in digestive oncology.
Events like the ABCD course are essential for energizing translational research. They create a platform for sharing advancements, fostering collaboration, and bridging the gap between laboratory discoveries and clinical applications. These discussions inspire new ideas and strategies to enhance patient care in oncology.
A special thanks to Unicancer Gastrointestinal (UCGI) Group for orchestrating such an impactful gathering, and to all the participants for their engagement and contributions.”
More posts featuring Nelson Dusetti.